Answer
The selected product is licensed for specified uses in children aged 2 to 12 years. Safety and efficacy below 2 years have not been established in its SmPC.
Sources for this answer
- Piperacillin/Tazobactam 4 g/0.5 g powder and solvent for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.